Camtek vs Cognex
CAMT and CGNX side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CAMT and CGNX compare
Cognex grew revenue faster over the last twelve months (17.1% versus 15.6% for Camtek).
Cognex keeps more of each dollar of sales as profit, with a net margin of 16.1% compared with 10.2% at Camtek.
Cognex pays a dividend yielding 0.53%; Camtek does not pay one.
Cognex scores higher on the StockData Score (17 against 12 for Camtek), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CAMT | CGNX |
|---|---|---|
| Size and price | ||
| Market cap | – | $8.2B |
| Share price | $94.96 | $48.50 |
| Change, 1 year | −1.3% | 31.9% |
| Change, 5 years | 114% | −36.3% |
| Beta (5Y) | 2.30 | 1.41 |
| Employees | 193 | 2,267 |
| StockData Score | ||
| Total score | 12 | 17 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 3 | 3 |
| Performance score | 4 (better) | 3 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 47.1× |
| P/S | – | 7.5× |
| P/B | – | 5.0× |
| EV/EBITDA | – | 32.5× |
| P/FCF | – | 30.4× |
| FCF yield | – | 3.3% |
| Fair value | – | $44.97 |
| Margin of safety | – | −7.8% |
| Growth | ||
| Revenue growth (TTM) | 15.6% | 17.1% (better) |
| Revenue growth, 5Y average | 26.1% (better) | 4.2% |
| Net income growth (TTM) | −57.2% | 43.2% (better) |
| EPS growth (TTM) | −57.0% | 45.1% (better) |
| EPS growth, 5Y average | 14.0% (better) | −7.4% |
| Profitability | ||
| Gross margin | 50.5% | 68.9% (better) |
| Operating margin | 25.8% (better) | 21.9% |
| Net margin | 10.2% | 16.1% (better) |
| FCF margin | 25.7% (better) | 24.6% |
| Return on equity | 8.7% | 11.1% (better) |
| Return on invested capital | 33.0% (better) | 12.9% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 8.35 (better) | 3.93 |
| Altman Z-score | – | 10.38 |
| Piotroski F-score | 7 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.53% |
| Payout ratio | – | 32.1% |
| Years of dividend growth | – | 4 |
| Dividend growth, 5Y average | – | −31.9% |
| Buyback yield | – | 1.9% |
| Shareholder yield | – | 2.4% |
| Ownership | ||
| Held by institutions | 43.4% | 104% |
| Held by insiders | 10.5% | 0.38% |
| Insider net buying, 12 months | −$5.1M (better) | −$34.8M |
| Short interest, % of float | 8.3% | 3.9% |
Go deeper
- CAMT stock overview
- CAMT income statement
- CAMT valuation and score
- CGNX stock overview
- CGNX income statement
- CGNX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.